Better Care for PFAS Patients Act of 2026

This bill requires the Agency for Toxic Substances and Disease Registry (ATSDR) to partner with the National Academies to assess PFAS health effects and create clinical recommendations within two years of enactment. It mandates that this assessment include input from PFAS-exposed communities and be updated every five years. The ATSDR must then issue and publicly post updated clinical guidance for healthcare providers on treating PFAS-related health effects within five years, with subsequent updates every five years. This directly affects individuals exposed to PFAS chemicals (found in water, food, and consumer products) and healthcare providers treating them.